Yuqiao Shen

3.2k total citations
26 papers, 2.4k citations indexed

About

Yuqiao Shen is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Yuqiao Shen has authored 26 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Oncology and 9 papers in Genetics. Recurrent topics in Yuqiao Shen's work include PARP inhibition in cancer therapy (12 papers), Virus-based gene therapy research (9 papers) and DNA Repair Mechanisms (9 papers). Yuqiao Shen is often cited by papers focused on PARP inhibition in cancer therapy (12 papers), Virus-based gene therapy research (9 papers) and DNA Repair Mechanisms (9 papers). Yuqiao Shen collaborates with scholars based in United States, United Kingdom and China. Yuqiao Shen's co-authors include Thomas Shenk, Bing Wang, Mika Aoyagi-Scharber, Ying Feng, Leonard Post, John Nemunaitis, Hua Zhu, Ying Feng, Farah Rehman and Julia Boshuizen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yuqiao Shen

26 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuqiao Shen United States 18 1.4k 1.4k 702 344 325 26 2.4k
Catherine Spenlehauer France 10 1.1k 0.8× 1.1k 0.8× 118 0.2× 213 0.6× 724 2.2× 11 2.3k
Christophe Briand Switzerland 20 550 0.4× 1.9k 1.4× 259 0.4× 225 0.7× 412 1.3× 29 2.6k
Christopher Cubitt United States 26 500 0.3× 691 0.5× 102 0.1× 200 0.6× 277 0.9× 57 1.7k
Jonathan N. Pruneda United States 22 836 0.6× 2.4k 1.7× 294 0.4× 590 1.7× 315 1.0× 48 2.9k
Farida Sarangi Canada 23 897 0.6× 1.6k 1.1× 576 0.8× 590 1.7× 201 0.6× 31 3.0k
Arthur E. Frankel United States 35 854 0.6× 1.4k 1.0× 541 0.8× 366 1.1× 1.6k 4.9× 107 3.4k
Miklós Békés United States 19 1.1k 0.7× 2.7k 1.9× 119 0.2× 226 0.7× 282 0.9× 23 3.3k
Jonathan Pol France 34 1.6k 1.1× 1.2k 0.8× 1.1k 1.5× 462 1.3× 1.2k 3.7× 80 3.3k
Richard Marcellus Canada 22 724 0.5× 2.4k 1.7× 909 1.3× 506 1.5× 483 1.5× 38 3.3k
Andrew M. Lewis United States 27 923 0.6× 1.2k 0.8× 1.2k 1.8× 117 0.3× 262 0.8× 77 2.0k

Countries citing papers authored by Yuqiao Shen

Since Specialization
Citations

This map shows the geographic impact of Yuqiao Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuqiao Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuqiao Shen more than expected).

Fields of papers citing papers by Yuqiao Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuqiao Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuqiao Shen. The network helps show where Yuqiao Shen may publish in the future.

Co-authorship network of co-authors of Yuqiao Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuqiao Shen. A scholar is included among the top collaborators of Yuqiao Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuqiao Shen. Yuqiao Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Babcock, Michael, Bing Wang, Sanjay Chandriani, et al.. (2021). Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor. Scientific Reports. 11(1). 14486–14486. 14 indexed citations
2.
Yang, Ying, Li Wu, Ge Sun, et al.. (2020). Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China. Frontiers in Pharmacology. 11. 1066–1066. 69 indexed citations
3.
Kizilbash, Sani H., Shiv K. Gupta, Kenneth Tou En Chang, et al.. (2017). Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma. Molecular Cancer Therapeutics. 16(12). 2735–2746. 60 indexed citations
4.
Cardnell, Robert J., Ying Feng, Lixia Diao, et al.. (2016). Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer. PLoS ONE. 11(4). e0152584–e0152584. 65 indexed citations
5.
Shen, Yuqiao, Mika Aoyagi-Scharber, & Bing Wang. (2015). Trapping Poly(ADP-Ribose) Polymerase. Journal of Pharmacology and Experimental Therapeutics. 353(3). 446–457. 166 indexed citations
6.
Aoyagi-Scharber, Mika, A.S. Gardberg, Bryan K. Yip, et al.. (2014). Structural basis for the inhibition of poly(ADP-ribose) polymerases 1 and 2 by BMN 673, a potent inhibitor derived from dihydropyridophthalazinone. Acta Crystallographica Section F Structural Biology Communications. 70(9). 1143–1149. 49 indexed citations
7.
Shen, Yuqiao, Farah Rehman, Ying Feng, et al.. (2013). BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency. Clinical Cancer Research. 19(18). 5003–5015. 378 indexed citations
8.
Cardnell, Robert J., Ying Feng, Lixia Diao, et al.. (2013). Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer. Clinical Cancer Research. 19(22). 6322–6328. 131 indexed citations
9.
McPherson, Lisa, Yuqiao Shen, & James M. Ford. (2013). Poly (ADP-ribose) polymerase inhibitor LT-626: Sensitivity correlates with MRE11 mutations and synergizes with platinums and irinotecan in colorectal cancer cells. Cancer Letters. 343(2). 217–223. 25 indexed citations
10.
Shen, Yuqiao, Ying Feng, Bing Wang, et al.. (2011). Abstract B64: Structure and preclinical characterization of BMN 673, a potent and orally active PARP inhibitor as an anticancer agent.. Molecular Cancer Therapeutics. 10(11_Supplement). B64–B64. 2 indexed citations
11.
Shen, Yuqiao, Neil Senzer, & John Nemunaitis. (2008). Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy. SHILAP Revista de lepidopterología. 3. DTI.S649–DTI.S649. 4 indexed citations
12.
Zhang, Yuan, et al.. (2006). Antitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering RNA. Cancer Research. 66(19). 9736–9743. 62 indexed citations
13.
Shen, Yuqiao, Neil Senzer, & John Nemunaitis. (2005). Individualised cancer therapeutics: dream or reality? Therapeutics construction. Expert Opinion on Biological Therapy. 5(11). 1427–1441. 4 indexed citations
14.
Senzer, Neil, Yuqiao Shen, Colin Hill, & John Nemunaitis. (2005). Individualised cancer therapeutics: dream or reality?. Expert Opinion on Therapeutic Targets. 9(6). 1189–1201. 9 indexed citations
15.
Zhan, Jinghui, Yi Gao, Wensheng Wang, et al.. (2004). Tumor-specific intravenous gene delivery using oncolytic adenoviruses. Cancer Gene Therapy. 12(1). 19–25. 18 indexed citations
16.
O’Shea, Clodagh C., Leisa Johnson, Serah Choi, et al.. (2004). Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity. Cancer Cell. 6(6). 611–623. 291 indexed citations
17.
Shen, Yuqiao & John Nemunaitis. (2004). Fighting Cancer with Vaccinia Virus: Teaching New Tricks to an Old Dog. Molecular Therapy. 11(2). 180–195. 89 indexed citations
18.
Shen, Yuqiao, Hua Zhu, & Thomas Shenk. (1997). Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate “hit-and-run” oncogenic transformation in cooperation with the adenovirus E1A proteins. Proceedings of the National Academy of Sciences. 94(7). 3341–3345. 151 indexed citations
19.
Shen, Yuqiao & Thomas Shenk. (1995). Viruses and apoptosis. Current Opinion in Genetics & Development. 5(1). 105–111. 295 indexed citations
20.
Shen, Yuqiao & Jeremy A. Bruenn. (1993). RNA Structural Requirements for RNA Binding, Replication, and Packaging in the Yeast Double-Stranded RNA Virus. Virology. 195(2). 481–491. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Spenlehauer Breakdown of academic impact, for papers by Christophe Briand Breakdown of academic impact, for papers by Christopher Cubitt Breakdown of academic impact, for papers by Jonathan N. Pruneda Breakdown of academic impact, for papers by Farida Sarangi Breakdown of academic impact, for papers by Arthur E. Frankel Breakdown of academic impact, for papers by Miklós Békés Breakdown of academic impact, for papers by Jonathan Pol Breakdown of academic impact, for papers by Richard Marcellus Breakdown of academic impact, for papers by Andrew M. Lewis
Rankless by CCL
2026